Drug treatment options in preeclampsia are limited because of the tendency of some antihypertensive drugs, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor (AT1) antagonists (sartans), to cause teratogenic effects on the fetus [5]. The gene discussed is ACE; the disease is preeclampsia.